Biotechnology
The Biotechnology industry has a total of 677 stocks, with a combined market cap of $1,429.32 billion and total revenue of $121.67 billion.
Market Cap
1,429.32B
Revenue
121.67B
Profits
-33.51B
PE Ratio
n/a
Profit Margin
-27.54%
Dividend Yield
0.10%
677 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 563.50B | 0.13% | 2,047,245 | 35.35B |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 109.52B | -1.28% | 363,142 | 10.19B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 106.08B | 0.22% | 128,440 | 13.10B |
| 4 | MRNA | Moderna, Inc. | 48.60B | 0.84% | 2,242,383 | 5.15B |
| 5 | BNTX | BioNTech SE | 21.84B | -0.95% | 161,191 | 2.97B |
| 6 | ARGX | argenx SE | 21.10B | -1.21% | 155,655 | 39.48M |
| 7 | GMAB | Genmab A/S | 19.11B | 0.58% | 397,514 | 2.57B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 18.73B | -1.21% | 207,376 | 2.00B |
| 9 | BGNE | BeiGene, Ltd. | 18.16B | -0.09% | 48,799 | 2.76B |
| 10 | BMRN | BioMarin Pharmaceutical Inc. | 15.13B | -1.04% | 699,167 | 2.47B |
| 11 | TECH | Bio-Techne Corporation | 13.15B | 1.76% | 408,984 | 1.15B |
| 12 | INCY | Incyte Corporation | 12.82B | -0.86% | 1,254,612 | 3.77B |
| 13 | RPRX | Royalty Pharma plc | 12.58B | -1.67% | 1,156,116 | 2.24B |
| 14 | SRPT | Sarepta Therapeutics, Inc. | 12.49B | 0.39% | 452,500 | 1.40B |
| 15 | UTHR | United Therapeutics Corporation | 11.89B | 1.41% | 184,021 | 2.50B |
| 16 | ROIV | Roivant Sciences Ltd. | 9.06B | 0.49% | 1,412,710 | 123.24M |
| 17 | VKTX | Viking Therapeutics, Inc. | 7.98B | -0.01% | 918,176 | - |
| 18 | LEGN | Legend Biotech Corporation | 7.95B | 1.70% | 558,967 | 342.80M |
| 19 | CERE | Cerevel Therapeutics Holdings, Inc. | 7.70B | 0.52% | 289,846 | - |
| 20 | ASND | Ascendis Pharma A/S | 7.33B | -1.97% | 262,298 | 357.63M |
| 21 | PCVX | Vaxcyte, Inc. | 7.24B | 1.29% | 97,004 | - |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 6.99B | -1.97% | 195,676 | 3.84B |
| 23 | BPMC | Blueprint Medicines Corporation | 6.66B | -1.55% | 185,833 | 282.21M |
| 24 | RVMD | Revolution Medicines, Inc. | 6.23B | 1.21% | 528,114 | 4.57M |
| 25 | CYTK | Cytokinetics, Incorporated | 6.09B | 0.79% | 1,244,957 | 3.75M |
| 26 | EXEL | Exelixis, Inc. | 6.09B | -1.86% | 795,005 | 1.85B |
| 27 | IBRX | ImmunityBio, Inc. | 5.64B | -3.42% | 4,981,593 | 302.00K |
| 28 | IONS | Ionis Pharmaceuticals, Inc. | 5.60B | -1.08% | 435,762 | 776.62M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 5.57B | 0.18% | 719,083 | 862.99M |
| 30 | BBIO | BridgeBio Pharma, Inc. | 5.38B | 0.95% | 473,435 | 218.60M |
| 31 | APLS | Apellis Pharmaceuticals, Inc. | 5.04B | -3.37% | 632,734 | 524.07M |
| 32 | CRSP | CRISPR Therapeutics AG | 4.72B | 0.02% | 1,212,912 | 271.71M |
| 33 | MDGL | Madrigal Pharmaceuticals, Inc. | 4.52B | 0.53% | 144,338 | - |
| 34 | KRYS | Krystal Biotech, Inc. | 4.50B | 1.82% | 47,311 | 95.95M |
| 35 | IMVT | Immunovant, Inc. | 4.46B | 2.64% | 589,183 | - |
| 36 | ALPN | Alpine Immune Sciences, Inc. | 4.46B | -0.01% | 750,389 | 56.52M |
| 37 | NUVL | Nuvalent, Inc. | 4.33B | 1.61% | 115,790 | - |
| 38 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.87B | 2.63% | 209,111 | 1.97M |
| 39 | INSM | Insmed Incorporated | 3.80B | -1.08% | 795,712 | 315.49M |
| 40 | AXSM | Axsome Therapeutics, Inc. | 3.63B | 1.07% | 218,475 | 251.02M |
| 41 | RARE | Ultragenyx Pharmaceutical Inc. | 3.41B | -0.07% | 259,081 | 442.59M |
| 42 | SMMT | Summit Therapeutics Inc. | 3.35B | -0.42% | 1,074,847 | - |
| 43 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.23B | 9.64% | 624,330 | - |
| 44 | SWTX | SpringWorks Therapeutics, Inc. | 3.15B | 2.70% | 259,941 | 26.45M |
| 45 | IDYA | IDEAYA Biosciences, Inc. | 3.14B | 1.49% | 161,074 | 15.50M |
| 46 | XENE | Xenon Pharmaceuticals Inc. | 3.09B | 0.94% | 141,514 | - |
| 47 | APGE | Apogee Therapeutics, Inc. | 3.07B | 3.22% | 1,543,170 | - |
| 48 | IOVA | Iovance Biotherapeutics, Inc. | 3.03B | -0.41% | 3,984,610 | 1.90M |
| 49 | CORT | Corcept Therapeutics Incorporated | 2.84B | -0.84% | 582,463 | 523.53M |
| 50 | IMCR | Immunocore Holdings plc | 2.83B | -0.71% | 108,931 | 264.25M |
| 51 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.80B | 2.52% | 801,784 | 35.47M |
| 52 | TGTX | TG Therapeutics, Inc. | 2.80B | 4.50% | 2,766,209 | 289.33M |
| 53 | DNLI | Denali Therapeutics Inc. | 2.79B | 1.24% | 331,772 | 295.39M |
| 54 | MOR | MorphoSys AG | 2.77B | 1.66% | 205,197 | 264.75M |
| 55 | FOLD | Amicus Therapeutics, Inc. | 2.76B | 3.10% | 1,868,936 | 423.49M |
| 56 | RNA | Avidity Biosciences, Inc. | 2.72B | 9.34% | 1,236,548 | 10.87M |
| 57 | ACLX | Arcellx, Inc. | 2.68B | 0.78% | 140,289 | 131.66M |
| 58 | MRUS | Merus N.V. | 2.67B | -0.46% | 256,729 | 38.34M |
| 59 | MLTX | MoonLake Immunotherapeutics | 2.63B | 0.05% | 56,892 | - |
| 60 | CLDX | Celldex Therapeutics, Inc. | 2.62B | -1.05% | 105,407 | 6.07M |
| 61 | FTRE | Fortrea Holdings Inc. | 2.58B | 2.74% | 1,759,663 | 3.11B |
| 62 | JANX | Janux Therapeutics, Inc. | 2.51B | -3.30% | 342,600 | 7.29M |
| 63 | NTLA | Intellia Therapeutics, Inc. | 2.49B | 1.38% | 642,058 | 52.60M |
| 64 | RYTM | Rhythm Pharmaceuticals, Inc. | 2.47B | 0.70% | 92,322 | 91.93M |
| 65 | ACAD | ACADIA Pharmaceuticals Inc. | 2.44B | -2.54% | 1,592,332 | 813.81M |
| 66 | PTCT | PTC Therapeutics, Inc. | 2.41B | -0.91% | 177,993 | 927.56M |
| 67 | VCEL | Vericel Corporation | 2.35B | -0.33% | 78,570 | 207.78M |
| 68 | RXRX | Recursion Pharmaceuticals, Inc. | 2.28B | 4.75% | 7,493,468 | 46.24M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.27B | 5.18% | 382,398 | - |
| 70 | VERA | Vera Therapeutics, Inc. | 2.23B | -0.37% | 164,573 | - |
| 71 | GERN | Geron Corporation | 2.21B | -0.27% | 2,834,771 | 520.00K |
| 72 | KYMR | Kymera Therapeutics, Inc. | 2.15B | -8.81% | 360,723 | 79.41M |
| 73 | ARVN | Arvinas, Inc. | 2.15B | -0.60% | 169,236 | 71.30M |
| 74 | RCKT | Rocket Pharmaceuticals, Inc. | 2.14B | 1.82% | 126,052 | - |
| 75 | ZLAB | Zai Lab Limited | 2.13B | 0.02% | 250,560 | 291.07M |
| 76 | ADMA | ADMA Biologics, Inc. | 2.08B | 1.82% | 2,136,842 | 283.18M |
| 77 | CPRX | Catalyst Pharmaceuticals, Inc. | 1.96B | 2.03% | 479,095 | 411.35M |
| 78 | BEAM | Beam Therapeutics Inc. | 1.95B | -1.12% | 578,449 | 360.91M |
| 79 | SANA | Sana Biotechnology, Inc. | 1.93B | 10.37% | 757,576 | - |
| 80 | AGIO | Agios Pharmaceuticals, Inc. | 1.92B | 0.64% | 209,375 | 29.40M |
| 81 | KROS | Keros Therapeutics, Inc. | 1.91B | -1.94% | 115,267 | 234.00K |
| 82 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.89B | 3.18% | 55,342,833 | 208.70M |
| 83 | GLPG | Galapagos NV | 1.88B | 0.14% | 30,125 | - |
| 84 | NAMS | NewAmsterdam Pharma Company N.V. | 1.87B | 2.67% | 88,486 | - |
| 85 | FUSN | Fusion Pharmaceuticals Inc. | 1.82B | 0.05% | 155,175 | 2.04M |
| 86 | NVAX | Novavax, Inc. | 1.81B | -1.72% | 47,618,938 | 996.61M |
| 87 | CGON | CG Oncology, Inc. | 1.80B | 4.37% | 980,465 | 539.00K |
| 88 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | 0.38% | 342,340 | - |
| 89 | ARDX | Ardelyx, Inc. | 1.79B | -4.55% | 1,689,344 | 159.11M |
| 90 | INBX | Inhibrx, Inc. | 1.79B | 0.25% | 177,490 | 1.78M |
| 91 | PTGX | Protagonist Therapeutics, Inc. | 1.74B | 1.48% | 115,519 | 314.95M |
| 92 | GPCR | Structure Therapeutics Inc. | 1.68B | 0.03% | 308,731 | - |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 1.68B | -2.27% | 119,821 | 617.51M |
| 94 | EWTX | Edgewise Therapeutics, Inc. | 1.60B | -1.40% | 510,760 | - |
| 95 | SLNO | Soleno Therapeutics, Inc. | 1.60B | 2.52% | 118,687 | - |
| 96 | KURA | Kura Oncology, Inc. | 1.58B | 0.97% | 279,257 | - |
| 97 | SYRE | Spyre Therapeutics, Inc. | 1.57B | 5.42% | 257,035 | 688.00K |
| 98 | RCUS | Arcus Biosciences, Inc. | 1.56B | -0.70% | 208,741 | 237.00M |
| 99 | LGND | Ligand Pharmaceuticals Incorporated | 1.53B | 1.14% | 68,017 | 118.31M |
| 100 | NMRA | Neumora Therapeutics, Inc. | 1.50B | 5.02% | 360,470 | - |
| 101 | TARS | Tarsus Pharmaceuticals, Inc. | 1.46B | 0.36% | 318,062 | 42.56M |
| 102 | AKRO | Akero Therapeutics, Inc. | 1.43B | -0.15% | 308,808 | - |
| 103 | MORF | Morphic Holding, Inc. | 1.43B | -0.66% | 87,808 | - |
| 104 | DAWN | Day One Biopharmaceuticals, Inc. | 1.42B | 1.31% | 133,441 | - |
| 105 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.42B | 1.57% | 1,104,731 | 274.10M |
| 106 | KNSA | Kiniksa Pharmaceuticals, Ltd. | 1.39B | -0.36% | 78,225 | 301.77M |
| 107 | VIR | Vir Biotechnology, Inc. | 1.37B | 3.28% | 222,862 | 79.60M |
| 108 | GYRE | Gyre Therapeutics, Inc. | 1.34B | -0.13% | 27,701 | 140.62M |
| 109 | FDMT | 4D Molecular Therapeutics, Inc. | 1.32B | 1.10% | 196,458 | 20.45M |
| 110 | XNCR | Xencor, Inc. | 1.28B | -2.25% | 274,852 | 162.18M |
| 111 | BLTE | Belite Bio, Inc | 1.25B | 0.26% | 11,826 | - |
| 112 | MNKD | MannKind Corporation | 1.21B | 0.68% | 720,251 | 224.60M |
| 113 | IMTX | Immatics N.V. | 1.20B | 6.68% | 1,181,088 | 60.00M |
| 114 | MIRM | Mirum Pharmaceuticals, Inc. | 1.16B | -0.28% | 120,632 | 224.00M |
| 115 | CGEM | Cullinan Oncology, Inc. | 1.16B | 3.10% | 337,420 | - |
| 116 | MDXG | MiMedx Group, Inc. | 1.16B | -0.63% | 432,322 | 334.51M |
| 117 | PHVS | Pharvaris N.V. | 1.14B | -0.17% | 14,232 | - |
| 118 | ELVN | Enliven Therapeutics, Inc. | 1.13B | -1.84% | 222,541 | - |
| 119 | ABCL | AbCellera Biologics Inc. | 1.13B | -0.26% | 771,152 | 35.79M |
| 120 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.12B | -3.20% | 1,488,779 | 355.40M |
| 121 | SRRK | Scholar Rock Holding Corporation | 1.11B | 2.42% | 185,388 | - |
| 122 | PRTA | Prothena Corporation plc | 1.11B | -0.68% | 233,176 | 89.25M |
| 123 | VRNA | Verona Pharma plc | 1.08B | 0.07% | 331,060 | - |
| 124 | SLN | Silence Therapeutics plc | 998.87M | 3.17% | 36,204 | 32.12M |
| 125 | INVA | Innoviva, Inc. | 990.06M | -2.04% | 299,609 | 311.59M |
| 126 | SAVA | Cassava Sciences, Inc. | 985.96M | 10.23% | 1,248,405 | - |
| 127 | TYRA | Tyra Biosciences, Inc. | 958.71M | -0.54% | 128,819 | - |
| 128 | PROK | ProKidney Corp. | 956.68M | 34.25% | 2,074,569 | - |
| 129 | VRDN | Viridian Therapeutics, Inc. | 947.13M | 3.28% | 212,089 | 288.00K |
| 130 | OCUL | Ocular Therapeutix, Inc. | 941.73M | 7.09% | 1,252,667 | 59.84M |
| 131 | ARQT | Arcutis Biotherapeutics, Inc. | 940.95M | 1.88% | 1,587,303 | 59.61M |
| 132 | BCYC | Bicycle Therapeutics plc | 940.05M | -2.30% | 114,368 | 41.61M |
| 133 | CNTA | Centessa Pharmaceuticals plc | 924.53M | 7.36% | 61,460 | 6.85M |
| 134 | NRIX | Nurix Therapeutics, Inc. | 898.66M | 8.39% | 1,046,697 | 80.89M |
| 135 | LQDA | Liquidia Corporation | 895.97M | -3.38% | 475,977 | 15.97M |
| 136 | ETNB | 89bio, Inc. | 885.95M | 3.62% | 369,165 | - |
| 137 | IMNM | Immunome, Inc. | 883.57M | -5.61% | 495,798 | 14.02M |
| 138 | ABVX | Abivax SA | 872.67M | -0.57% | 21,263 | 5.13M |
| 139 | SPRY | ARS Pharmaceuticals, Inc. | 861.39M | - | 239,065 | 10.00K |
| 140 | PLRX | Pliant Therapeutics, Inc. | 847.58M | 2.78% | 506,226 | 248.00K |
| 141 | ZNTL | Zentalis Pharmaceuticals, Inc. | 833.69M | - | 188,746 | 40.56M |
| 142 | RLAY | Relay Therapeutics, Inc. | 829.64M | -2.65% | 427,708 | 35.33M |
| 143 | MESO | Mesoblast Limited | 828.54M | 3.80% | 115,505 | 7.25M |
| 144 | DNTH | Dianthus Therapeutics, Inc. | 812.96M | 7.46% | 42,613 | 2.26M |
| 145 | TNGX | Tango Therapeutics, Inc. | 797.31M | 2.19% | 206,027 | 37.23M |
| 146 | PRAX | Praxis Precision Medicines, Inc. | 795.85M | 2.43% | 123,228 | 2.20M |
| 147 | PRME | Prime Medicine, Inc. | 793.39M | 2.88% | 552,774 | 591.00K |
| 148 | LBPH | Longboard Pharmaceuticals, Inc. | 787.52M | 1.96% | 60,542 | - |
| 149 | IRON | Disc Medicine, Inc. | 783.18M | 2.42% | 121,977 | - |
| 150 | RGNX | REGENXBIO Inc. | 781.94M | 1.11% | 144,823 | 86.73M |
| 151 | ARCT | Arcturus Therapeutics Holdings Inc. | 776.17M | 0.50% | 178,512 | 124.53M |
| 152 | HUMA | Humacyte, Inc. | 771.66M | 18.70% | 4,085,239 | - |
| 153 | CRGX | CARGO Therapeutics, Inc. | 770.84M | 0.46% | 44,162 | - |
| 154 | ALXO | ALX Oncology Holdings Inc. | 764.55M | -2.95% | 149,140 | - |
| 155 | PRTC | PureTech Health plc | 749.86M | -1.75% | 23 | 3.33M |
| 156 | SAGE | Sage Therapeutics, Inc. | 740.84M | 0.70% | 603,442 | 91.06M |
| 157 | AUPH | Aurinia Pharmaceuticals Inc. | 733.69M | 1.99% | 828,875 | 191.41M |
| 158 | NUVB | Nuvation Bio Inc. | 719.55M | -2.37% | 638,299 | - |
| 159 | WVE | Wave Life Sciences Ltd. | 718.01M | 3.16% | 208,279 | 112.91M |
| 160 | COGT | Cogent Biosciences, Inc. | 707.54M | 0.27% | 339,780 | - |
| 161 | ANAB | AnaptysBio, Inc. | 685.70M | 4.34% | 71,140 | 22.96M |
| 162 | AUTL | Autolus Therapeutics plc | 685.09M | -2.37% | 532,539 | 1.70M |
| 163 | CVAC | CureVac N.V. | 681.72M | 2.69% | 219,073 | 59.73M |
| 164 | GHRS | GH Research PLC | 675.32M | 0.78% | 24,109 | - |
| 165 | HLVX | HilleVax, Inc. | 671.23M | -0.81% | 146,927 | - |
| 166 | SVRA | Savara Inc. | 663.25M | 4.36% | 361,209 | - |
| 167 | EYPT | EyePoint Pharmaceuticals, Inc. | 662.51M | 4.09% | 575,853 | 50.02M |
| 168 | KYTX | Kyverna Therapeutics, Inc. | 660.96M | 5.13% | 237,401 | - |
| 169 | PHAR | Pharming Group N.V. | 649.20M | 2.55% | 2,566 | 280.83M |
| 170 | LYEL | Lyell Immunopharma, Inc. | 645.63M | 5.83% | 228,208 | 68.00K |
| 171 | ZYME | Zymeworks Inc. | 640.23M | -2.27% | 289,316 | 50.46M |
| 172 | MLYS | Mineralys Therapeutics, Inc. | 637.02M | -0.77% | 30,734 | - |
| 173 | STOK | Stoke Therapeutics, Inc. | 623.61M | 3.20% | 359,455 | 7.85M |
| 174 | ENGN | enGene Holdings Inc. | 617.85M | -1.55% | 566 | - |
| 175 | EXAI | Exscientia plc | 616.57M | -0.41% | 220,626 | 25.42M |
| 176 | AVBP | ArriVent BioPharma, Inc. | 614.78M | 0.33% | 17,696 | - |
| 177 | ITOS | iTeos Therapeutics, Inc. | 612.13M | -0.35% | 354,802 | - |
| 178 | ORIC | ORIC Pharmaceuticals, Inc. | 607.81M | 0.11% | 99,144 | - |
| 179 | CALT | Calliditas Therapeutics AB (publ) | 604.31M | 4.18% | 4,785 | 119.73M |
| 180 | MNMD | Mind Medicine (MindMed) Inc. | 604.19M | 1.42% | 623,101 | - |
| 181 | PHAT | Phathom Pharmaceuticals, Inc. | 596.36M | 5.27% | 356,453 | 2.59M |
| 182 | ADPT | Adaptive Biotechnologies Corporation | 584.31M | 4.34% | 1,207,542 | 174.50M |
| 183 | CDMO | Avid Bioservices, Inc. | 564.97M | 1.02% | 806,759 | 136.74M |
| 184 | VALN | Valneva SE | 561.24M | 7.30% | 11,996 | 166.26M |
| 185 | ALT | Altimmune, Inc. | 558.65M | 6.78% | 1,970,832 | 410.00K |
| 186 | ABSI | Absci Corporation | 552.79M | -3.36% | 451,187 | 5.72M |
| 187 | OLMA | Olema Pharmaceuticals, Inc. | 549.83M | 6.51% | 509,544 | - |
| 188 | IGMS | IGM Biosciences, Inc. | 548.56M | 0.76% | 93,307 | 2.11M |
| 189 | AVTE | Aerovate Therapeutics, Inc. | 547.30M | -0.63% | 168,965 | - |
| 190 | ABUS | Arbutus Biopharma Corporation | 535.01M | -2.42% | 271,086 | 12.99M |
| 191 | CABA | Cabaletta Bio, Inc. | 532.64M | 1.15% | 221,153 | - |
| 192 | ATXS | Astria Therapeutics, Inc. | 527.17M | -1.13% | 127,035 | - |
| 193 | KALV | KalVista Pharmaceuticals, Inc. | 525.67M | 3.79% | 128,557 | - |
| 194 | THRD | Third Harmonic Bio, Inc. | 522.91M | 6.38% | 27,702 | - |
| 195 | OABI | OmniAb, Inc. | 522.38M | -0.56% | 412,696 | 21.05M |
| 196 | CELC | Celcuity Inc. | 518.92M | 1.61% | 23,239 | - |
| 197 | YMAB | Y-mAbs Therapeutics, Inc. | 518.69M | -2.79% | 232,896 | 84.50M |
| 198 | APLT | Applied Therapeutics, Inc. | 514.09M | 1.58% | 571,706 | -477.00K |
| 199 | ALEC | Alector, Inc. | 513.73M | -1.11% | 204,465 | 96.41M |
| 200 | LRMR | Larimar Therapeutics, Inc. | 505.93M | 8.33% | 172,940 | - |
| 201 | TVTX | Travere Therapeutics, Inc. | 499.41M | 3.47% | 584,930 | 183.23M |
| 202 | ALLO | Allogene Therapeutics, Inc. | 495.95M | - | 5,026,073 | 65.00K |
| 203 | TRDA | Entrada Therapeutics, Inc. | 492.88M | 4.06% | 43,057 | 162.87M |
| 204 | FULC | Fulcrum Therapeutics, Inc. | 489.15M | 7.07% | 756,486 | 2.51M |
| 205 | VERV | Verve Therapeutics, Inc. | 485.43M | -0.56% | 808,033 | 16.05M |
| 206 | TSHA | Taysha Gene Therapies, Inc. | 480.62M | 6.88% | 1,909,868 | 15.45M |
| 207 | FATE | Fate Therapeutics, Inc. | 478.60M | 1.33% | 1,226,896 | 6.48M |
| 208 | EDIT | Editas Medicine, Inc. | 470.61M | 0.35% | 937,731 | 69.41M |
| 209 | LXRX | Lexicon Pharmaceuticals, Inc. | 467.85M | 1.07% | 1,047,226 | 2.31M |
| 210 | URGN | UroGen Pharma Ltd. | 466.62M | -1.26% | 207,672 | 84.30M |
| 211 | VYGR | Voyager Therapeutics, Inc. | 464.20M | 0.65% | 325,671 | 119.04M |
| 212 | CBUS | Cibus, Inc. | 463.11M | 0.29% | 52,767 | 2.32M |
| 213 | LXEO | Lexeo Therapeutics, Inc. | 462.91M | 4.24% | 48,409 | - |
| 214 | SLRN | Acelyrin, Inc. | 461.88M | 1.28% | 280,399 | - |
| 215 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 460.49M | 0.07% | 43,789 | - |
| 216 | TBPH | Theravance Biopharma, Inc. | 457.08M | -1.15% | 150,191 | 57.42M |
| 217 | NKTX | Nkarta, Inc. | 451.70M | -2.51% | 1,228,313 | - |
| 218 | BMEA | Biomea Fusion, Inc. | 443.74M | 7.69% | 617,775 | - |
| 219 | OCGN | Ocugen, Inc. | 442.55M | -5.25% | 7,273,061 | 6.04M |
| 220 | OCS | Oculis Holding AG | 441.63M | -0.41% | 40,625 | 995.46K |
| 221 | ANNX | Annexon, Inc. | 440.21M | -1.23% | 926,954 | - |
| 222 | PEPG | PepGen Inc. | 435.98M | 1.35% | 46,290 | - |
| 223 | VRCA | Verrica Pharmaceuticals Inc. | 434.42M | 7.32% | 732,230 | 8.91M |
| 224 | STTK | Shattuck Labs, Inc. | 428.91M | -12.95% | 1,562,495 | 2.72M |
| 225 | HRTX | Heron Therapeutics, Inc. | 425.59M | 0.36% | 783,413 | 132.10M |
| 226 | MREO | Mereo BioPharma Group plc | 419.48M | -0.17% | 315,086 | 10.00M |
| 227 | CCCC | C4 Therapeutics, Inc. | 409.39M | -3.57% | 764,118 | 20.04M |
| 228 | REPL | Replimune Group, Inc. | 403.32M | - | 254,235 | - |
| 229 | KRRO | Korro Bio, Inc. | 400.53M | -0.64% | 11,184 | - |
| 230 | LENZ | LENZ Therapeutics, Inc. | 397.30M | -2.45% | 38,225 | - |
| 231 | TCRX | TScan Therapeutics, Inc. | 396.47M | 7.37% | 138,480 | 14.81M |
| 232 | NGNE | Neurogene Inc. | 389.44M | -1.21% | 48,872 | - |
| 233 | TERN | Terns Pharmaceuticals, Inc. | 387.40M | 1.70% | 546,621 | - |
| 234 | CTNM | Contineum Therapeutics, Inc. | 384.04M | -0.52% | 14,168 | 50.00M |
| 235 | SLDB | Solid Biosciences Inc. | 382.96M | 3.08% | 48,703 | - |
| 236 | TRML | Tourmaline Bio, Inc. | 378.29M | 1.87% | 260,714 | - |
| 237 | RNAC | Cartesian Therapeutics, Inc. | 376.74M | 13.05% | 62,117 | 25.91M |
| 238 | AURA | Aura Biosciences, Inc. | 371.00M | 3.48% | 60,797 | - |
| 239 | FBLG | FibroBiologics, Inc. | 369.40M | 11.04% | 67,854 | - |
| 240 | ANRO | Alto Neuroscience, Inc. | 369.12M | -2.48% | 17,243 | - |
| 241 | IMMP | Immutep Limited | 367.05M | -0.34% | 31,849 | 4.58M |
| 242 | AVXL | Anavex Life Sciences Corp. | 362.32M | 7.64% | 943,127 | - |
| 243 | NAUT | Nautilus Biotechnology, Inc. | 357.01M | 5.13% | 67,058 | - |
| 244 | ACIU | AC Immune SA | 355.13M | 6.36% | 2,770,696 | 16.82M |
| 245 | STRO | Sutro Biopharma, Inc. | 354.86M | 2.84% | 335,070 | 154.07M |
| 246 | RVNC | Revance Therapeutics, Inc. | 353.29M | 2.41% | 2,726,204 | 236.65M |
| 247 | NBTX | Nanobiotix S.A. | 344.28M | 6.69% | 5,747 | 40.23M |
| 248 | SKYE | Skye Bioscience, Inc. | 341.39M | 6.75% | 129,386 | - |
| 249 | PGEN | Precigen, Inc. | 339.50M | - | 356,336 | 6.23M |
| 250 | TNYA | Tenaya Therapeutics, Inc. | 338.40M | 1.05% | 78,160 | - |
| 251 | QTTB | Q32 Bio Inc. | 334.86M | 2.77% | 18,730 | 354.00K |
| 252 | MGTX | MeiraGTx Holdings plc | 334.72M | 1.36% | 52,295 | 697.00K |
| 253 | AVIR | Atea Pharmaceuticals, Inc. | 331.42M | -2.72% | 142,100 | - |
| 254 | CRBU | Caribou Biosciences, Inc. | 331.01M | -1.21% | 942,492 | 33.40M |
| 255 | NKTR | Nektar Therapeutics | 326.67M | 1.14% | 1,009,754 | 90.17M |
| 256 | ERAS | Erasca, Inc. | 322.45M | -2.11% | 170,324 | - |
| 257 | JSPR | Jasper Therapeutics, Inc. | 320.19M | 1.59% | 26,129 | - |
| 258 | ATAI | Atai Life Sciences N.V. | 319.93M | -0.52% | 274,675 | 314.00K |
| 259 | VSTM | Verastem, Inc. | 319.38M | 4.95% | 120,360 | - |
| 260 | MRSN | Mersana Therapeutics, Inc. | 318.75M | -0.76% | 1,145,515 | 38.30M |
| 261 | ADCT | ADC Therapeutics SA | 317.18M | -8.11% | 395,126 | 68.62M |
| 262 | CADL | Candel Therapeutics, Inc. | 311.08M | 3.92% | 365,792 | - |
| 263 | ZURA | Zura Bio Limited | 309.76M | 3.76% | 204,415 | - |
| 264 | RANI | Rani Therapeutics Holdings, Inc. | 309.02M | 0.33% | 41,141 | - |
| 265 | GUTS | Fractyl Health, Inc. | 307.14M | 5.08% | 188,985 | 148.00K |
| 266 | BDTX | Black Diamond Therapeutics, Inc. | 306.78M | -1.85% | 270,010 | - |
| 267 | OPT | Opthea Limited | 304.06M | -0.81% | 27,297 | 385.28K |
| 268 | INO | Inovio Pharmaceuticals, Inc. | 301.81M | 1.50% | 284,722 | 717.07K |
| 269 | ATNM | Actinium Pharmaceuticals, Inc. | 301.41M | 14.45% | 626,961 | 81.00K |
| 270 | VTYX | Ventyx Biosciences, Inc. | 298.56M | 2.91% | 338,348 | - |
| 271 | VNDA | Vanda Pharmaceuticals Inc. | 294.48M | 0.10% | 460,865 | 177.60M |
| 272 | XOMA | XOMA Corporation | 291.81M | -3.55% | 8,605 | 5.81M |
| 273 | CRMD | CorMedix Inc. | 288.76M | -0.94% | 285,107 | - |
| 274 | IVVD | Invivyd, Inc. | 287.32M | 1.48% | 221,759 | - |
| 275 | INZY | Inozyme Pharma, Inc. | 285.46M | 2.44% | 161,072 | - |
| 276 | XERS | Xeris Biopharma Holdings, Inc. | 283.17M | 1.06% | 1,266,887 | 171.36M |
| 277 | MGNX | MacroGenics, Inc. | 280.90M | 2.63% | 4,011,348 | 43.36M |
| 278 | ENTA | Enanta Pharmaceuticals, Inc. | 280.84M | 2.87% | 55,243 | 72.88M |
| 279 | PSTX | Poseida Therapeutics, Inc. | 280.09M | 2.49% | 247,637 | 64.70M |
| 280 | CDXC | ChromaDex Corporation | 269.67M | 5.62% | 118,697 | 83.17M |
| 281 | QSI | Quantum-Si incorporated | 268.88M | 9.88% | 1,029,480 | 1.29M |
| 282 | CYBN | Cybin Inc. | 267.65M | -1.92% | 2,225,052 | - |
| 283 | EPIX | ESSA Pharma Inc. | 265.01M | 1.03% | 20,593 | - |
| 284 | ACRV | Acrivon Therapeutics, Inc. | 260.13M | -0.47% | 58,378 | - |
| 285 | ADAP | Adaptimmune Therapeutics plc | 260.11M | -2.14% | 326,748 | 60.28M |
| 286 | AKBA | Akebia Therapeutics, Inc. | 259.90M | -4.26% | 1,482,358 | 187.23M |
| 287 | XBIT | XBiotech Inc. | 259.48M | -0.12% | 17,272 | - |
| 288 | IPSC | Century Therapeutics, Inc. | 259.31M | 4.00% | 46,940 | 1.37M |
| 289 | CDXS | Codexis, Inc. | 259.30M | 1.39% | 429,504 | 74.23M |
| 290 | DSGN | Design Therapeutics, Inc. | 255.36M | -0.66% | 73,235 | - |
| 291 | GLUE | Monte Rosa Therapeutics, Inc. | 250.12M | 0.40% | 38,783 | 1.06M |
| 292 | GTHX | G1 Therapeutics, Inc. | 248.34M | 2.81% | 424,895 | 84.04M |
| 293 | TSVT | 2seventy bio, Inc. | 246.74M | 6.68% | 306,937 | 71.20M |
| 294 | PYXS | Pyxis Oncology, Inc. | 245.81M | -2.91% | 404,924 | - |
| 295 | ALDX | Aldeyra Therapeutics, Inc. | 245.08M | 9.73% | 441,248 | - |
| 296 | MGX | Metagenomi, Inc. | 243.95M | -0.23% | 77,446 | 44.76M |
| 297 | PBYI | Puma Biotechnology, Inc. | 243.61M | -1.85% | 213,583 | 226.63M |
| 298 | GBIO | Generation Bio Co. | 238.70M | 23.94% | 305,144 | 9.96M |
| 299 | QURE | uniQure N.V. | 237.11M | 0.10% | 224,625 | 19.00M |
| 300 | FHTX | Foghorn Therapeutics Inc. | 231.24M | -4.14% | 41,846 | 33.90M |
| 301 | CHRS | Coherus BioSciences, Inc. | 228.70M | -3.35% | 1,645,732 | 301.87M |
| 302 | AGEN | Agenus Inc. | 228.58M | -1.85% | 272,436 | 161.42M |
| 303 | OMER | Omeros Corporation | 227.14M | 4.93% | 201,282 | - |
| 304 | ELYM | Eliem Therapeutics, Inc. | 226.50M | -2.08% | 125,991 | - |
| 305 | ABOS | Acumen Pharmaceuticals, Inc. | 224.03M | 10.71% | 142,927 | - |
| 306 | OVID | Ovid Therapeutics Inc. | 222.98M | 3.64% | 75,185 | 391.70K |
| 307 | CMPX | Compass Therapeutics, Inc. | 222.89M | 3.85% | 298,759 | - |
| 308 | CDT | Conduit Pharmaceuticals Inc. | 222.22M | -5.83% | 37,105 | - |
| 309 | MACK | Merrimack Pharmaceuticals, Inc. | 219.98M | 0.26% | 410,336 | - |
| 310 | BOLD | Boundless Bio, Inc. | 216.17M | 2.21% | 33,867 | - |
| 311 | PRLD | Prelude Therapeutics Incorporated | 214.77M | 2.89% | 10,338 | - |
| 312 | CLLS | Cellectis S.A. | 214.54M | 0.67% | 16,348 | 9.19M |
| 313 | HOWL | Werewolf Therapeutics, Inc. | 212.71M | 9.42% | 146,294 | 16.22M |
| 314 | ANL | Adlai Nortye Ltd. | 211.53M | -0.71% | 2,638 | 5.00M |
| 315 | IPHA | Innate Pharma S.A. | 207.76M | 4.45% | 9,683 | 68.49M |
| 316 | VERU | Veru Inc. | 206.39M | 5.64% | 2,057,459 | 13.48M |
| 317 | CRVO | CervoMed Inc. | 204.69M | 1.43% | 9,214 | 7.14M |
| 318 | BLUE | bluebird bio, Inc. | 204.31M | 3.92% | 4,981,242 | 21.73M |
| 319 | INMB | INmune Bio, Inc. | 203.74M | 3.83% | 48,752 | 131.00K |
| 320 | LCTX | Lineage Cell Therapeutics, Inc. | 203.15M | -0.92% | 1,595,450 | 8.00M |
| 321 | TRVI | Trevi Therapeutics, Inc. | 201.44M | 4.76% | 30,661 | - |
| 322 | ZVRA | Zevra Therapeutics, Inc. | 201.32M | -1.84% | 116,232 | 28.01M |
| 323 | FENC | Fennec Pharmaceuticals Inc. | 199.97M | -26.65% | 897,622 | 21.25M |
| 324 | KOD | Kodiak Sciences Inc. | 199.06M | -1.83% | 161,394 | - |
| 325 | ELEV | Elevation Oncology, Inc. | 192.87M | -0.28% | 264,304 | - |
| 326 | ATOS | Atossa Therapeutics, Inc. | 190.61M | 4.45% | 1,128,031 | - |
| 327 | IVA | Inventiva S.A. | 187.49M | 0.56% | 3,754 | 25.74M |
| 328 | TELO | Telomir Pharmaceuticals, Inc. | 185.81M | -4.32% | 7,434 | - |
| 329 | YS | YS Biopharma Co., Ltd. | 183.86M | 5.88% | 41,333 | - |
| 330 | GNFT | Genfit S.A. | 183.84M | -2.63% | 703 | 42.42M |
| 331 | CGEN | Compugen Ltd. | 183.54M | 0.99% | 150,827 | 33.46M |
| 332 | ADVM | Adverum Biotechnologies, Inc. | 183.27M | -3.93% | 130,118 | - |
| 333 | GALT | Galectin Therapeutics Inc. | 181.69M | -4.55% | 86,385 | - |
| 334 | DRTS | Alpha Tau Medical Ltd. | 178.73M | -4.29% | 2,431 | - |
| 335 | GLSI | Greenwich LifeSciences, Inc. | 175.79M | 4.52% | 10,700 | - |
| 336 | OTLK | Outlook Therapeutics, Inc. | 173.11M | -1.86% | 177,796 | - |
| 337 | ACHV | Achieve Life Sciences, Inc. | 170.75M | 3.64% | 128,591 | - |
| 338 | OBIO | Orchestra BioMed Holdings, Inc. | 170.70M | 6.52% | 2,248 | 2.22M |
| 339 | ABEO | Abeona Therapeutics Inc. | 169.26M | -1.86% | 820,374 | 3.50M |
| 340 | MDWD | MediWound Ltd. | 169.05M | 1.59% | 8,041 | 18.69M |
| 341 | XFOR | X4 Pharmaceuticals, Inc. | 168.78M | 2.91% | 1,226,137 | - |
| 342 | GOSS | Gossamer Bio, Inc. | 167.40M | 2.78% | 1,614,189 | - |
| 343 | RIGL | Rigel Pharmaceuticals, Inc. | 167.06M | -3.02% | 704,087 | 120.35M |
| 344 | SCPH | scPharmaceuticals Inc. | 166.21M | 5.86% | 190,067 | 13.59M |
| 345 | CAPR | Capricor Therapeutics, Inc. | 164.45M | -4.04% | 462,511 | 25.18M |
| 346 | TVGN | Tevogen Bio Holdings Inc. | 162.80M | -1.10% | 1,303,175 | - |
| 347 | CRDF | Cardiff Oncology, Inc. | 161.46M | 3.74% | 695,006 | 610.00K |
| 348 | PRQR | ProQR Therapeutics N.V. | 159.27M | 1.01% | 66,357 | 14.66M |
| 349 | RPTX | Repare Therapeutics Inc. | 158.38M | 1.62% | 193,617 | 97.86M |
| 350 | VXRT | Vaxart, Inc. | 153.04M | 3.49% | 2,048,288 | 8.89M |
| 351 | RENB | Renovaro Biosciences Inc. | 147.98M | -9.48% | 180,120 | - |
| 352 | SYRS | Syros Pharmaceuticals, Inc. | 145.94M | 7.71% | 119,786 | 9.94M |
| 353 | IMAB | I-Mab | 142.88M | 2.54% | 122,286 | 3.90M |
| 354 | RAPT | RAPT Therapeutics, Inc. | 142.16M | -7.16% | 763,615 | - |
| 355 | CRVS | Corvus Pharmaceuticals, Inc. | 141.37M | 6.64% | 410,668 | - |
| 356 | SEER | Seer, Inc. | 140.26M | 8.29% | 681,075 | 15.67M |
| 357 | VIGL | Vigil Neuroscience, Inc. | 139.75M | 1.92% | 37,383 | - |
| 358 | SGMT | Sagimet Biosciences Inc. | 139.46M | 3.42% | 210,827 | 2.00M |
| 359 | RGLS | Regulus Therapeutics Inc. | 135.84M | -0.24% | 409,401 | - |
| 360 | MCRB | Seres Therapeutics, Inc. | 134.00M | -9.34% | 3,009,334 | 126.85M |
| 361 | CTMX | CytomX Therapeutics, Inc. | 130.48M | 1.32% | 3,812,169 | 119.18M |
| 362 | KPTI | Karyopharm Therapeutics Inc. | 130.07M | -1.34% | 1,136,429 | 140.46M |
| 363 | PDSB | PDS Biotechnology Corporation | 129.18M | -1.81% | 457,575 | - |
| 364 | CNTX | Context Therapeutics Inc. | 128.62M | 1.79% | 70,044 | - |
| 365 | BCAB | BioAtla, Inc. | 128.20M | 0.95% | 519,493 | - |
| 366 | OMGA | Omega Therapeutics, Inc. | 127.07M | -3.61% | 292,023 | 4.94M |
| 367 | AMLX | Amylyx Pharmaceuticals, Inc. | 127.00M | 2.20% | 948,869 | 398.00M |
| 368 | DBVT | DBV Technologies S.A. | 124.30M | 6.48% | 96,209 | 14.94M |
| 369 | CTXR | Citius Pharmaceuticals, Inc. | 124.20M | -2.39% | 705,411 | - |
| 370 | LIFE | aTyr Pharma, Inc. | 123.39M | 5.00% | 257,232 | 588.00K |
| 371 | VTGN | VistaGen Therapeutics, Inc. | 122.69M | - | 102,449 | 1.04M |
| 372 | NVCT | Nuvectis Pharma, Inc. | 122.43M | 4.57% | 36,655 | - |
| 373 | MOLN | Molecular Partners AG | 122.11M | -0.62% | 1,396 | 8.38M |
| 374 | SGMO | Sangamo Therapeutics, Inc. | 120.12M | 4.46% | 1,417,389 | 18.76M |
| 375 | COYA | Coya Therapeutics, Inc. | 119.74M | 2.41% | 25,953 | 6.13M |
| 376 | FGEN | FibroGen, Inc. | 117.76M | -2.07% | 865,700 | 167.49M |
| 377 | DMAC | DiaMedica Therapeutics Inc. | 116.93M | -2.98% | 19,885 | - |
| 378 | IMUX | Immunic, Inc. | 116.65M | 3.59% | 88,509 | - |
| 379 | CLRB | Cellectar Biosciences, Inc. | 114.60M | 4.41% | 558,624 | - |
| 380 | RZLT | Rezolute, Inc. | 114.36M | -0.35% | 61,729 | - |
| 381 | VOR | Vor Biopharma Inc. | 113.24M | -2.06% | 119,115 | - |
| 382 | LPTX | Leap Therapeutics, Inc. | 111.96M | 3.18% | 125,679 | - |
| 383 | ACET | Adicet Bio, Inc. | 111.55M | -5.90% | 501,130 | - |
| 384 | RLMD | Relmada Therapeutics, Inc. | 109.68M | 2.97% | 55,241 | - |
| 385 | ARMP | Armata Pharmaceuticals, Inc. | 108.46M | -8.72% | 15,011 | 4.70M |
| 386 | PMVP | PMV Pharmaceuticals, Inc. | 106.69M | -2.58% | 195,121 | - |
| 387 | ALLK | Allakos Inc. | 105.37M | -2.46% | 189,574 | - |
| 388 | ELTX | Elicio Therapeutics, Inc. | 104.42M | 5.80% | 63,069 | - |
| 389 | BYSI | BeyondSpring Inc. | 103.78M | 3.10% | 25,203 | 1.75M |
| 390 | VANI | Vivani Medical, Inc. | 98.96M | -2.43% | 242,921 | - |
| 391 | ORMP | Oramed Pharmaceuticals Inc. | 98.46M | 0.83% | 52,994 | 674.00K |
| 392 | ADAG | Adagene Inc. | 96.55M | -1.84% | 1,623 | 18.11M |
| 393 | ANIX | Anixa Biosciences, Inc. | 95.86M | 1.18% | 20,165 | 210.00K |
| 394 | GNLX | Genelux Corporation | 94.16M | -3.88% | 96,222 | 8.00K |
| 395 | IOBT | IO Biotech, Inc. | 93.55M | - | 55,961 | - |
| 396 | CLSD | Clearside Biomedical, Inc. | 92.67M | 4.07% | 149,394 | 8.45M |
| 397 | CRIS | Curis, Inc. | 91.42M | -0.96% | 25,777 | 9.81M |
| 398 | MIST | Milestone Pharmaceuticals Inc. | 90.89M | 1.18% | 22,485 | - |
| 399 | ANVS | Annovis Bio, Inc. | 90.25M | 15.47% | 519,891 | - |
| 400 | CMRX | Chimerix, Inc. | 89.62M | -4.77% | 215,699 | 41.00K |
| 401 | ALVR | AlloVir, Inc. | 89.15M | 3.19% | 137,092 | - |
| 402 | ONCY | Oncolytics Biotech Inc. | 89.00M | 0.85% | 140,108 | - |
| 403 | BRNS | Barinthus Biotherapeutics plc | 88.24M | -6.39% | 1,861 | 334.00K |
| 404 | SPRO | Spero Therapeutics, Inc. | 87.04M | -2.12% | 76,695 | 103.78M |
| 405 | ATHA | Athira Pharma, Inc. | 85.85M | -2.16% | 68,910 | - |
| 406 | CNTB | Connect Biopharma Holdings Limited | 84.40M | 10.57% | 63,884 | - |
| 407 | PASG | Passage Bio, Inc. | 83.79M | -8.78% | 113,876 | - |
| 408 | IFRX | InflaRx N.V. | 83.61M | 13.60% | 232,784 | 107.75K |
| 409 | PLX | Protalix BioTherapeutics, Inc. | 83.58M | - | 191,578 | 59.65M |
| 410 | JAGX | Jaguar Health, Inc. | 83.38M | 0.65% | 56,470,766 | 9.76M |
| 411 | GRTS | Gritstone bio, Inc. | 81.42M | -0.62% | 1,411,776 | 15.65M |
| 412 | DTIL | Precision BioSciences, Inc. | 80.02M | -0.04% | 15,425 | 57.53M |
| 413 | ENTX | Entera Bio Ltd. | 79.83M | -3.85% | 205,744 | - |
| 414 | BTAI | BioXcel Therapeutics, Inc. | 79.62M | -1.83% | 241,918 | 1.76M |
| 415 | AFMD | Affimed N.V. | 79.34M | -1.33% | 13,595 | 9.19M |
| 416 | SLS | SELLAS Life Sciences Group, Inc. | 79.11M | -0.73% | 661,449 | - |
| 417 | LVTX | LAVA Therapeutics N.V. | 78.45M | -2.48% | 120,492 | 7.52M |
| 418 | HOOK | HOOKIPA Pharma Inc. | 77.62M | 4.98% | 277,427 | 53.55M |
| 419 | PALI | Palisade Bio, Inc. | 77.15M | 0.56% | 47,055 | - |
| 420 | CUE | Cue Biopharma, Inc. | 77.10M | -4.24% | 449,706 | 7.02M |
| 421 | CGTX | Cognition Therapeutics, Inc. | 76.71M | -2.05% | 101,770 | - |
| 422 | CELU | Celularity Inc. | 76.02M | 16.50% | 54,711 | 14.79M |
| 423 | ASMB | Assembly Biosciences, Inc. | 75.53M | 2.32% | 5,691 | - |
| 424 | MRNS | Marinus Pharmaceuticals, Inc. | 75.50M | 1.48% | 701,955 | 28.29M |
| 425 | CLGN | CollPlant Biotechnologies Ltd. | 74.77M | -1.26% | 1,687 | 10.96M |
| 426 | CVM | CEL-SCI Corporation | 74.72M | 0.35% | 308,364 | - |
| 427 | TPST | Tempest Therapeutics, Inc. | 74.37M | 1.83% | 320,488 | - |
| 428 | TIL | Instil Bio, Inc. | 73.95M | -4.37% | 7,679 | - |
| 429 | MNOV | MediciNova, Inc. | 72.69M | -0.54% | 24,755 | 1.00M |
| 430 | ATRA | Atara Biotherapeutics, Inc. | 72.36M | 8.09% | 1,137,050 | 34.70M |
| 431 | SER | Serina Therapeutics Inc | 71.18M | 3.93% | 11,323 | 142.00K |
| 432 | RLYB | Rallybio Corporation | 69.57M | 3.37% | 58,136 | - |
| 433 | LABP | Landos Biopharma, Inc. | 69.55M | - | 1,297 | - |
| 434 | ANTX | AN2 Therapeutics, Inc. | 69.50M | -0.85% | 36,487 | - |
| 435 | TARA | Protara Therapeutics, Inc. | 68.77M | 3.09% | 676,345 | - |
| 436 | TSBX | Turnstone Biologics Corp. | 68.47M | -2.28% | 46,984 | 19.31M |
| 437 | LTRN | Lantern Pharma Inc. | 66.49M | 0.76% | 38,046 | - |
| 438 | ALRN | Aileron Therapeutics, Inc. | 65.37M | 0.52% | 38,603 | - |
| 439 | MURA | Mural Oncology plc | 64.47M | 1.60% | 42,442 | - |
| 440 | AEON | AEON Biopharma, Inc. | 63.99M | -1.79% | 33,999 | - |
| 441 | IKNA | Ikena Oncology, Inc. | 63.94M | 0.38% | 83,475 | 3.85M |
| 442 | VTVT | vTv Therapeutics Inc. | 63.23M | 0.35% | 3,550 | 1.00M |
| 443 | CSBR | Champions Oncology, Inc. | 63.08M | -0.85% | 3,619 | 49.22M |
| 444 | GNTA | Genenta Science S.p.A. | 62.85M | -4.44% | 2,045 | - |
| 445 | INTS | Intensity Therapeutics, Inc. | 61.69M | 13.75% | 101,146 | - |
| 446 | CARM | Carisma Therapeutics, Inc. | 61.07M | - | 113,380 | 15.07M |
| 447 | KRON | Kronos Bio, Inc. | 60.09M | -1.96% | 167,151 | 7.59M |
| 448 | ANEB | Anebulo Pharmaceuticals, Inc. | 59.52M | -4.77% | 9,958 | - |
| 449 | CDTX | Cidara Therapeutics, Inc. | 58.94M | 0.59% | 26,198 | 63.91M |
| 450 | THTX | Theratechnologies Inc. | 58.86M | 9.40% | 21,247 | 57.85M |
| 451 | IMMX | Immix Biopharma, Inc. | 58.09M | 0.69% | 80,079 | - |
| 452 | KZR | Kezar Life Sciences, Inc. | 57.66M | 4.36% | 1,108,014 | 7.00M |
| 453 | AVRO | AVROBIO, Inc. | 57.46M | -3.33% | 222,369 | - |
| 454 | TLSA | Tiziana Life Sciences Ltd | 57.29M | -4.93% | 82,786 | - |
| 455 | ELDN | Eledon Pharmaceuticals, Inc. | 55.29M | 5.02% | 103,740 | - |
| 456 | CKPT | Checkpoint Therapeutics, Inc. | 54.40M | 0.97% | 199,104 | 68.00K |
| 457 | EQ | Equillium, Inc. | 53.94M | -0.91% | 79,274 | 37.89M |
| 458 | RPHM | Reneo Pharmaceuticals, Inc. | 53.49M | 1.19% | 1,240,809 | - |
| 459 | ALGS | Aligos Therapeutics, Inc. | 51.76M | 2.10% | 166,949 | 13.79M |
| 460 | OCEA | Ocean Biomedical, Inc. | 51.63M | -1.32% | 70,730 | - |
| 461 | BLRX | BioLineRx Ltd. | 50.15M | 0.51% | 67,052 | 4.80M |
| 462 | OKYO | OKYO Pharma Limited | 49.53M | 0.68% | 245,372 | - |
| 463 | CLNN | Clene Inc. | 49.42M | -1.54% | 314,808 | 620.00K |
| 464 | BOLT | Bolt Biotherapeutics, Inc. | 49.18M | -3.01% | 46,432 | 7.88M |
| 465 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 48.03M | 1.47% | 312,853 | - |
| 466 | IMRX | Immuneering Corporation | 47.45M | 1.57% | 71,310 | - |
| 467 | MLEC | Moolec Science SA | 46.95M | 4.76% | 107,748 | 2.90M |
| 468 | ABIO | ARCA biopharma, Inc. | 46.58M | -5.56% | 47,200 | - |
| 469 | AADI | Aadi Bioscience, Inc. | 45.79M | -0.53% | 146,729 | 23.84M |
| 470 | INAB | IN8bio, Inc. | 45.78M | 2.97% | 79,194 | - |
| 471 | NXTC | NextCure, Inc. | 44.48M | 0.63% | 24,795 | - |
| 472 | HCWB | HCW Biologics Inc. | 44.25M | -1.68% | 6,100 | 560.36K |
| 473 | GANX | Gain Therapeutics, Inc. | 44.23M | 2.89% | 169,956 | 55.18K |
| 474 | OCUP | Ocuphire Pharma, Inc. | 44.17M | 2.92% | 64,030 | 19.01M |
| 475 | CTCX | Carmell Therapeutics Corporation | 43.69M | 0.95% | 8,899 | - |
| 476 | DYAI | Dyadic International, Inc. | 43.12M | - | 13,091 | 2.90M |
| 477 | MTNB | Matinas BioPharma Holdings, Inc. | 42.86M | 0.18% | 552,205 | - |
| 478 | EYEN | Eyenovia, Inc. | 42.74M | 2.84% | 749,686 | 3.79K |
| 479 | ICCC | ImmuCell Corporation | 42.52M | 3.13% | 1,456 | 17.47M |
| 480 | XLO | Xilio Therapeutics, Inc. | 41.71M | 0.89% | 109,034 | - |
| 481 | UNCY | Unicycive Therapeutics, Inc. | 40.80M | -0.46% | 120,993 | - |
| 482 | VYNE | VYNE Therapeutics Inc. | 40.69M | 3.07% | 22,976 | 423.00K |
| 483 | NTRB | Nutriband Inc. | 40.59M | 0.84% | 7,816 | 2.09M |
| 484 | LEXX | Lexaria Bioscience Corp. | 40.40M | -2.04% | 71,085 | 386.00K |
| 485 | QNCX | Quince Therapeutics, Inc. | 39.46M | -0.77% | 192,639 | - |
| 486 | SNSE | Sensei Biotherapeutics, Inc. | 39.25M | -0.32% | 54,842 | - |
| 487 | MAIA | MAIA Biotechnology, Inc. | 39.19M | -4.92% | 104,149 | - |
| 488 | CARA | Cara Therapeutics, Inc. | 39.16M | -3.69% | 219,903 | 16.94M |
| 489 | ESLA | Estrella Immunopharma, Inc. | 38.44M | -0.19% | 4,875 | - |
| 490 | PTN | Palatin Technologies, Inc. | 38.41M | -2.14% | 151,648 | 7.10M |
| 491 | INKT | MiNK Therapeutics, Inc. | 37.89M | 11.76% | 388,607 | - |
| 492 | ACHL | Achilles Therapeutics plc | 37.80M | 4.51% | 42,129 | - |
| 493 | IGC | IGC Pharma Inc | 37.43M | 8.19% | 592,582 | 1.22M |
| 494 | SABS | SAB Biotherapeutics, Inc. | 37.09M | -6.01% | 8,596 | 2.24M |
| 495 | PMN | ProMIS Neurosciences, Inc. | 36.79M | -3.00% | 1,417 | - |
| 496 | MRKR | Marker Therapeutics, Inc. | 36.77M | -0.73% | 4,771 | 3.31M |
| 497 | EVGN | Evogene Ltd. | 34.90M | 0.81% | 11,446 | 5.64M |
| 498 | BCLI | Brainstorm Cell Therapeutics Inc. | 34.78M | -8.74% | 373,867 | - |
| 499 | PLUR | Pluri Inc. | 34.65M | 5.24% | 7,432 | 341.00K |
| 500 | RNXT | RenovoRx, Inc. | 34.61M | - | 8,936 | - |
| 501 | NRXP | NRx Pharmaceuticals, Inc. | 34.41M | 7.36% | 175,395 | - |
| 502 | BCTX | BriaCell Therapeutics Corp. | 34.04M | -2.74% | 13,250 | - |
| 503 | FBIO | Fortress Biotech, Inc. | 33.86M | 4.71% | 106,467 | 84.51M |
| 504 | SPRB | Spruce Biosciences, Inc. | 33.55M | 1.28% | 193,882 | 10.13M |
| 505 | CASI | CASI Pharmaceuticals, Inc. | 32.97M | -1.59% | 7,964 | 33.88M |
| 506 | APLM | Apollomics, Inc. | 32.76M | -0.87% | 123,314 | - |
| 507 | ACXP | Acurx Pharmaceuticals, Inc. | 32.44M | -0.72% | 37,320 | - |
| 508 | SRZN | Surrozen, Inc. | 31.73M | 0.75% | 11,048 | - |
| 509 | DARE | Daré Bioscience, Inc. | 31.39M | -1.70% | 345,620 | 2.81M |
| 510 | APRE | Aprea Therapeutics, Inc. | 31.33M | 8.87% | 7,166 | 583.23K |
| 511 | IPA | ImmunoPrecise Antibodies Ltd. | 31.32M | -6.27% | 98,418 | 17.67M |
| 512 | VIRX | Viracta Therapeutics, Inc. | 30.96M | 3.46% | 23,231 | - |
| 513 | ICU | SeaStar Medical Holding Corporation | 28.64M | -3.43% | 2,415,772 | - |
| 514 | LPCN | Lipocine Inc. | 28.37M | 0.66% | 14,201 | 4.71M |
| 515 | BIVI | BioVie Inc. | 27.17M | 3.23% | 404,597 | - |
| 516 | ENLV | Enlivex Therapeutics Ltd. | 27.05M | 2.04% | 56,834 | - |
| 517 | FBRX | Forte Biosciences, Inc. | 26.97M | -5.56% | 5,732 | - |
| 518 | NKGN | NKGen Biotech, Inc. | 26.54M | -6.45% | 143,388 | - |
| 519 | UBX | Unity Biotechnology, Inc. | 26.35M | 0.32% | 109,329 | - |
| 520 | ONCT | Oncternal Therapeutics, Inc. | 26.28M | 2.08% | 2,783 | 1.15M |
| 521 | BIOR | Biora Therapeutics, Inc. | 26.20M | -2.16% | 189,394 | 4.00K |
| 522 | ACST | Acasti Pharma Inc. | 25.85M | -0.72% | 5,742 | - |
| 523 | NNVC | NanoViricides, Inc. | 25.32M | 17.03% | 508,395 | - |
| 524 | APM | Aptorum Group Limited | 25.29M | -4.29% | 20,260 | 431.38K |
| 525 | LSTA | Lisata Therapeutics, Inc. | 24.71M | 8.06% | 2,545 | - |
| 526 | ITRM | Iterum Therapeutics plc | 24.67M | -2.63% | 48,336 | - |
| 527 | GDTC | CytoMed Therapeutics Limited | 23.89M | 2.99% | 148 | - |
| 528 | LYRA | Lyra Therapeutics, Inc. | 22.33M | 1.02% | 3,105,170 | 1.68M |
| 529 | ORGS | Orgenesis Inc. | 21.51M | 3.28% | 8,139 | 530.00K |
| 530 | BNTC | Benitec Biopharma Inc. | 21.26M | 0.12% | 14,888 | 7.00K |
| 531 | MEIP | MEI Pharma, Inc. | 21.12M | 5.61% | 6,739 | 66.75M |
| 532 | VINC | Vincerx Pharma, Inc. | 21.09M | 1.27% | 160,039 | - |
| 533 | LUMO | Lumos Pharma, Inc. | 21.00M | -9.27% | 49,713 | 2.05M |
| 534 | TCRT | Alaunos Therapeutics, Inc. | 20.99M | 3.23% | 8,983 | 5.00K |
| 535 | SYBX | Synlogic, Inc. | 20.70M | -1.94% | 80,379 | 3.37M |
| 536 | AIM | AIM ImmunoTech Inc. | 20.10M | -6.82% | 409,893 | 202.00K |
| 537 | NRSN | NeuroSense Therapeutics Ltd. | 19.93M | 3.12% | 42,900 | - |
| 538 | NRXS | NeurAxis, Inc. | 19.66M | -0.96% | 11,553 | 2.46M |
| 539 | NRBO | NeuroBo Pharmaceuticals, Inc. | 19.43M | 1.77% | 7,845 | - |
| 540 | EVAX | Evaxion Biotech A/S | 19.40M | -2.11% | 10,670 | 73.00K |
| 541 | APTO | Aptose Biosciences Inc. | 19.34M | 0.85% | 60,266 | - |
| 542 | KALA | Kala Pharmaceuticals, Inc. | 19.21M | -2.70% | 6,120 | - |
| 543 | SLGL | Sol-Gel Technologies Ltd. | 18.94M | 0.29% | 2,624 | 1.55M |
| 544 | PHGE | BiomX Inc. | 18.85M | 0.32% | 27,937 | - |
| 545 | COCP | Cocrystal Pharma, Inc. | 18.82M | 5.71% | 11,786 | - |
| 546 | GLTO | Galecto, Inc. | 18.68M | -1.56% | 86,641 | - |
| 547 | ATHE | Alterity Therapeutics Limited | 18.27M | 0.49% | 36,457 | - |
| 548 | INDP | Indaptus Therapeutics, Inc. | 18.10M | 13.49% | 25,250 | - |
| 549 | VBIV | VBI Vaccines Inc. | 17.98M | -0.40% | 30,984 | 8.68M |
| 550 | CDIO | Cardio Diagnostics Holdings, Inc. | 17.78M | -10.61% | 604,719 | 17.07K |
| 551 | PMCB | PharmaCyte Biotech, Inc. | 17.75M | 2.94% | 5,456 | - |
| 552 | GLYC | GlycoMimetics, Inc. | 17.67M | 4.50% | 1,390,246 | 10.00K |
| 553 | NERV | Minerva Neurosciences, Inc. | 17.62M | 4.84% | 7,522 | - |
| 554 | SNTI | Senti Biosciences, Inc. | 17.20M | 3.92% | 15,226 | 1.28M |
| 555 | TRAW | Traws Pharma, Inc. | 16.34M | 0.19% | 35,397 | 226.00K |
| 556 | IBIO | iBio, Inc. | 16.28M | 4.11% | 122,108 | 50.00K |
| 557 | TNXP | Tonix Pharmaceuticals Holding Corp. | 15.55M | 5.20% | 3,179,666 | 10.25M |
| 558 | XTLB | XTL Biopharmaceuticals Ltd. | 14.53M | -3.08% | 16,250 | - |
| 559 | EDSA | Edesa Biotech, Inc. | 14.48M | 2.97% | 4,259 | - |
| 560 | ADXN | Addex Therapeutics Ltd | 14.13M | 0.97% | 2,386 | 1.96M |
| 561 | PIRS | Pieris Pharmaceuticals, Inc. | 13.88M | 0.09% | 3,399 | 42.81M |
| 562 | PPBT | Purple Biotech Ltd. | 13.79M | 1.72% | 59,964 | - |
| 563 | IMRN | Immuron Limited | 13.34M | -0.38% | 5,745 | 2.43M |
| 564 | ERNA | Eterna Therapeutics Inc. | 13.20M | 5.38% | 44,413 | 68.00K |
| 565 | KPRX | Kiora Pharmaceuticals, Inc. | 13.12M | -0.92% | 86,291 | 16.00M |
| 566 | COEP | Coeptis Therapeutics, Inc. | 13.00M | -2.02% | 17,201 | - |
| 567 | DOMH | Dominari Holdings Inc. | 12.55M | 0.49% | 2,651 | 3.41M |
| 568 | CHRO | Chromocell Therapeutics Corp | 12.44M | -16.36% | 20,262 | - |
| 569 | IMNN | Imunon, Inc. | 12.41M | -10.81% | 46,448 | - |
| 570 | CMMB | Chemomab Therapeutics Ltd. | 12.23M | 5.65% | 47,551 | - |
| 571 | MNPR | Monopar Therapeutics Inc. | 11.76M | -2.78% | 52,398 | - |
| 572 | ABVC | ABVC BioPharma, Inc. | 11.30M | 0.93% | 198,857 | 152.43K |
| 573 | CANF | Can-Fite BioPharma Ltd. | 11.16M | 1.03% | 5,961 | 743.00K |
| 574 | ELAB | Elevai Labs, Inc. | 11.09M | -2.81% | 43,145 | 1.71M |
| 575 | ONVO | Organovo Holdings, Inc. | 11.09M | 3.04% | 140,306 | 242.00K |
| 576 | CLDI | Calidi Biotherapeutics, Inc. | 11.04M | 1.44% | 173,029 | - |
| 577 | AVTX | Avalo Therapeutics, Inc. | 10.82M | -3.96% | 45,771 | 1.45M |
| 578 | BCDA | BioCardia, Inc. | 10.48M | -2.04% | 37,835 | 477.00K |
| 579 | FRES | Fresh2 Group Ltd | 10.37M | -11.29% | 140,540 | 2.35M |
| 580 | MBRX | Moleculin Biotech, Inc. | 10.31M | - | 594 | - |
| 581 | BNOX | Bionomics Limited | 10.27M | 3.50% | 78,672 | 15.00K |
| 582 | AEZS | Aeterna Zentaris Inc. | 10.15M | 1.46% | 10,053 | 4.50M |
| 583 | AKTX | Akari Therapeutics, Plc | 9.93M | -2.01% | 16,218 | - |
| 584 | NTBL | Notable Labs, Ltd. | 9.92M | -7.39% | 131,604 | 310.00K |
| 585 | IKT | Inhibikase Therapeutics, Inc. | 9.62M | 5.84% | 14,488 | 260.50K |
| 586 | GRTX | Galera Therapeutics, Inc. | 9.50M | -0.85% | 619,390 | - |
| 587 | EFTR | eFFECTOR Therapeutics, Inc. | 9.27M | -1.50% | 100,477 | - |
| 588 | PSTV | Plus Therapeutics, Inc. | 9.11M | 0.46% | 26,331 | 4.91M |
| 589 | LGVN | Longeveron Inc. | 9.08M | 10.38% | 535,782 | 709.00K |
| 590 | BRTX | BioRestorative Therapies, Inc. | 9.00M | -0.76% | 153,300 | 145.80K |
| 591 | MTEM | Molecular Templates, Inc. | 8.85M | -5.67% | 27,484 | 57.31M |
| 592 | CYCN | Cyclerion Therapeutics, Inc. | 8.54M | -3.39% | 344 | - |
| 593 | VCNX | Vaccinex, Inc. | 8.12M | 2.17% | 5,255 | 570.00K |
| 594 | NCNA | NuCana plc | 7.90M | 1.88% | 7,400 | - |
| 595 | PYPD | PolyPid Ltd. | 7.84M | 1.56% | 138 | - |
| 596 | TRVN | Trevena, Inc. | 7.50M | -4.65% | 98,516 | 3.13M |
| 597 | ASLN | ASLAN Pharmaceuticals Limited | 7.38M | 2.39% | 96,507 | 12.00M |
| 598 | OGEN | Oragenics, Inc. | 7.33M | 7.20% | 60,293 | 37.65K |
| 599 | CVKD | Cadrenal Therapeutics, Inc. | 7.17M | 3.32% | 80,058 | - |
| 600 | KTTA | Pasithea Therapeutics Corp. | 7.08M | -2.17% | 1,603 | - |
| 601 | VIRI | Virios Therapeutics, Inc. | 7.05M | 3.97% | 52,051 | - |
| 602 | KTRA | Kintara Therapeutics, Inc. | 7.02M | -8.04% | 4,005,321 | - |
| 603 | HEPA | Hepion Pharmaceuticals, Inc. | 6.95M | 6.72% | 45,443 | - |
| 604 | TENX | Tenax Therapeutics, Inc. | 6.80M | 0.28% | 35,977 | - |
| 605 | KZIA | Kazia Therapeutics Limited | 6.62M | -1.04% | 55,752 | 15.65K |
| 606 | PULM | Pulmatrix, Inc. | 6.57M | - | 4,899 | 11.68M |
| 607 | ENVB | Enveric Biosciences, Inc. | 6.40M | -4.41% | 665,146 | - |
| 608 | TOVX | Theriva Biologics, Inc. | 6.39M | -1.10% | 84,977 | - |
| 609 | LIXT | Lixte Biotechnology Holdings, Inc. | 6.34M | 7.66% | 4,585 | - |
| 610 | PCSA | Processa Pharmaceuticals, Inc. | 6.20M | -1.35% | 63,914 | - |
| 611 | FWBI | First Wave BioPharma, Inc. | 6.18M | -4.48% | 31,175 | - |
| 612 | TFFP | TFF Pharmaceuticals, Inc. | 6.01M | 8.51% | 23,967 | 733.87K |
| 613 | TTNP | Titan Pharmaceuticals, Inc. | 6.00M | 0.18% | 967 | 184.00K |
| 614 | CELZ | Creative Medical Technology Holdings, Inc. | 5.87M | 0.23% | 4,850 | 9.00K |
| 615 | XBIO | Xenetic Biosciences, Inc. | 5.85M | -1.30% | 759 | 2.44M |
| 616 | KA | Kineta, Inc. | 5.85M | -0.94% | 38,299 | 5.44M |
| 617 | HOTH | Hoth Therapeutics, Inc. | 5.82M | -0.83% | 12,772 | - |
| 618 | ADIL | Adial Pharmaceuticals, Inc. | 5.68M | -3.11% | 96,894 | - |
| 619 | SNGX | Soligenix, Inc. | 5.65M | 1.69% | 168,682 | 699.21K |
| 620 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 5.57M | -1.10% | 26,677 | 129.18K |
| 621 | NLSP | NLS Pharmaceutics AG | 5.53M | -0.50% | 33,737 | - |
| 622 | PTIX | Protagenic Therapeutics, Inc. | 5.41M | -4.69% | 9,556 | - |
| 623 | GNPX | Genprex, Inc. | 5.34M | 4.52% | 129,635 | - |
| 624 | MYMD | MyMD Pharmaceuticals, Inc. | 5.14M | -5.77% | 14,211 | - |
| 625 | SILO | Silo Pharma, Inc. | 5.12M | 2.27% | 16,463 | 72.10K |
| 626 | PRTG | Portage Biotech Inc. | 5.11M | -3.67% | 116,120 | - |
| 627 | AZTR | Azitra, Inc. | 5.04M | -4.31% | 714,430 | 572.70K |
| 628 | SNPX | Synaptogenix, Inc. | 4.87M | 0.62% | 47,512 | - |
| 629 | XRTX | XORTX Therapeutics Inc. | 4.82M | -4.96% | 14,912 | - |
| 630 | RNAZ | TransCode Therapeutics, Inc. | 4.79M | 17.25% | 3,755,484 | - |
| 631 | LIPO | Lipella Pharmaceuticals Inc. | 4.69M | -4.53% | 16,155 | 477.45K |
| 632 | NEXI | NexImmune, Inc. | 4.68M | -0.29% | 20,383 | - |
| 633 | DRUG | Bright Minds Biosciences Inc. | 4.54M | 0.96% | 13,176 | - |
| 634 | TCON | TRACON Pharmaceuticals, Inc. | 4.48M | -2.57% | 68,232 | 12.05M |
| 635 | ARTL | Artelo Biosciences, Inc. | 4.42M | 3.08% | 10,357 | - |
| 636 | GTBP | GT Biopharma, Inc. | 4.42M | 1.27% | 4,062 | - |
| 637 | THAR | Tharimmune, Inc. | 4.42M | 0.87% | 53,370 | - |
| 638 | ADTX | Aditxt, Inc. | 4.26M | 3.33% | 37,043 | 645.18K |
| 639 | XCUR | Exicure, Inc. | 4.15M | 0.36% | 2,437 | 23.79M |
| 640 | CMND | Clearmind Medicine Inc. | 4.12M | 0.78% | 114,302 | - |
| 641 | ALZN | Alzamend Neuro, Inc. | 4.12M | 21.13% | 433,945 | - |
| 642 | SEEL | Seelos Therapeutics, Inc. | 4.09M | -11.74% | 991,076 | 2.20M |
| 643 | ENSC | Ensysce Biosciences, Inc. | 4.03M | -6.30% | 311,608 | - |
| 644 | ZVSA | ZyVersa Therapeutics, Inc. | 3.98M | -2.38% | 50,046 | - |
| 645 | BPTH | Bio-Path Holdings, Inc. | 3.96M | 0.78% | 54,494 | - |
| 646 | GOVX | GeoVax Labs, Inc. | 3.81M | -0.61% | 41,514 | - |
| 647 | TCBP | TC Biopharm (Holdings) Plc | 3.64M | 1.77% | 327,046 | - |
| 648 | PHIO | Phio Pharmaceuticals Corp. | 3.44M | 8.92% | 46,417 | - |
| 649 | CYCC | Cyclacel Pharmaceuticals, Inc. | 3.44M | 3.94% | 158,566 | 420.00K |
| 650 | MBIO | Mustang Bio, Inc. | 3.42M | 5.81% | 304,506 | - |
| 651 | APVO | Aptevo Therapeutics Inc. | 3.34M | 0.96% | 161,279 | - |
| 652 | CING | Cingulate Inc. | 3.30M | 5.29% | 54,220 | - |
| 653 | NBY | NovaBay Pharmaceuticals, Inc. | 3.26M | 8.30% | 1,463,595 | 14.23M |
| 654 | CYTO | Altamira Therapeutics Ltd. | 3.23M | -2.70% | 37,361 | - |
| 655 | QNRX | Quoin Pharmaceuticals, Ltd. | 3.04M | 1.98% | 44,226 | - |
| 656 | FNCH | Finch Therapeutics Group, Inc. | 3.03M | 0.53% | 4,175 | - |
| 657 | SPRC | SciSparc Ltd. | 3.03M | -1.59% | 89,467 | 2.88M |
| 658 | REVB | Revelation Biosciences, Inc. | 3.02M | -0.54% | 41,046 | - |
| 659 | SCPX | Scorpius Holdings, Inc. | 2.99M | -54.66% | 12,607,485 | 6.99M |
| 660 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.66M | 2.31% | 45,654 | 253.57K |
| 661 | SCNI | Scinai Immunotherapeutics Ltd. | 2.56M | -2.18% | 22,938 | - |
| 662 | VRPX | Virpax Pharmaceuticals, Inc. | 2.51M | -22.73% | 68,264 | - |
| 663 | ONCO | Onconetix, Inc. | 2.46M | -0.99% | 237,150 | 58.47K |
| 664 | ATXI | Avenue Therapeutics, Inc. | 2.37M | 0.76% | 58,226 | - |
| 665 | SLRX | Salarius Pharmaceuticals, Inc. | 2.29M | -0.42% | 62,062 | - |
| 666 | GLMD | Galmed Pharmaceuticals Ltd. | 2.28M | 1.27% | 49,146 | - |
| 667 | DRMA | Dermata Therapeutics, Inc. | 2.26M | -10.50% | 103,284 | - |
| 668 | CNSP | CNS Pharmaceuticals, Inc. | 2.22M | -0.14% | 127,634 | - |
| 669 | WINT | Windtree Therapeutics, Inc. | 2.21M | 7.76% | 15,522 | - |
| 670 | QLGN | Qualigen Therapeutics, Inc. | 1.96M | 7.17% | 230,806 | - |
| 671 | ALLR | Allarity Therapeutics, Inc. | 1.91M | -0.45% | 4,289,598 | - |
| 672 | VRAX | Virax Biolabs Group Limited | 1.80M | -4.19% | 26,070 | 79.30K |
| 673 | ATNF | 180 Life Sciences Corp. | 1.70M | -2.83% | 10,177 | - |
| 674 | INM | InMed Pharmaceuticals Inc. | 1.63M | 2.51% | 63,127 | 5.49M |
| 675 | GRI | GRI Bio, Inc. | 1.53M | -0.74% | 275,467 | - |
| 676 | NBSE | NeuBase Therapeutics, Inc. | 1.42M | -1.56% | 97,744 | - |
| 677 | BDRX | Biodexa Pharmaceuticals Plc | 250.73K | 11.71% | 289,680 | 482.28K |